{"id":"https://openalex.org/W2396005266","doi":null,"title":"The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.","display_name":"The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.","publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W2396005266","mag":"2396005266","pmid":"https://pubmed.ncbi.nlm.nih.gov/18048963"},"language":"en","primary_location":{"id":"pmid:18048963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18048963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059394858","display_name":"Anna Haduch","orcid":"https://orcid.org/0000-0002-3925-3828","observed_orcids":["https://orcid.org/0000-0002-3925-3828"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Haduch","raw_affiliation_strings":["Department of Pharmacokinetics and Drug Metabolism, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics and Drug Metabolism, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Krak\u00f3w, Poland","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008157954","display_name":"Jacek W\u00f3jcikowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacek W\u00f3jcikowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075074462","display_name":"W\u0142adys\u0142awa Anna Daniel","orcid":"https://orcid.org/0000-0002-1226-1721","observed_orcids":["https://orcid.org/0000-0002-1226-1721"]},"institutions":[{"id":"https://openalex.org/I4391012572","display_name":"Akademickie Centrum Komputerowe Cyfronet AGH","ror":"https://ror.org/0575jwx13","country_code":"PL","type":"education","lineage":["https://openalex.org/I4391012572"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"W\u0142adys\u0142awa A Daniel","raw_affiliation_strings":["Academic Computer Centre CYFRONET AGH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Computer Centre CYFRONET AGH","institution_ids":["https://openalex.org/I4391012572"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8088,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.66084123,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"59","issue":"5","first_page":"606","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp2b","display_name":"CYP2B","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.9169999957084656},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-induced-enzyme-inhibition","display_name":"drug-induced enzyme inhibition","score":0.5090000033378601},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.9409999847412109},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.8849999904632568},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.9589999914169312},{"id":"https://openalex.org/keywords/perazine","display_name":"perazine","score":0.906000018119812},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.8799999952316284},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sertindole","display_name":"sertindole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/promazine","display_name":"promazine","score":0.7910000085830688},{"id":"https://openalex.org/keywords/levomepromazine","display_name":"levomepromazine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/phenothiazines","display_name":"phenothiazines","score":0.8640000224113464},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8230000138282776}],"concepts":[{"id":"https://openalex.org/C2780656706","wikidata":"https://www.wikidata.org/wiki/Q417204","display_name":"Levomepromazine","level":4,"score":0.9203077554702759},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.8882968425750732},{"id":"https://openalex.org/C2780777758","wikidata":"https://www.wikidata.org/wiki/Q418050","display_name":"Sertindole","level":4,"score":0.8751105070114136},{"id":"https://openalex.org/C2776484668","wikidata":"https://www.wikidata.org/wiki/Q419822","display_name":"Promazine","level":3,"score":0.8393075466156006},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.8248049020767212},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7557017803192139},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7050323486328125},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6935552358627319},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.47598162293434143},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.4289368689060211},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26363182067871094},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.24786314368247986},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22412261366844177},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.12256073951721191},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12039506435394287},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.09458443522453308},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D013250","descriptor_name":"Steroid Hydroxylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013739","descriptor_name":"Testosterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019362","descriptor_name":"Cytochrome P-450 CYP2B1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:18048963","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18048963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.455.1027","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.455.1027","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rabbit.if-pan.krakow.pl/pjp/pdf/2007/5_606.pdf","raw_type":"text"},{"id":"mag:2396005266","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18048963","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W37725492","https://openalex.org/W76739639","https://openalex.org/W204723001","https://openalex.org/W1465738810","https://openalex.org/W1553151860","https://openalex.org/W1990565207","https://openalex.org/W1997365504","https://openalex.org/W2000106454","https://openalex.org/W2009712270","https://openalex.org/W2012825509","https://openalex.org/W2035736822","https://openalex.org/W2044695596","https://openalex.org/W2051259012","https://openalex.org/W2052428509","https://openalex.org/W2061720023","https://openalex.org/W2063704076","https://openalex.org/W2081152882","https://openalex.org/W2082069949","https://openalex.org/W2083135851","https://openalex.org/W2092435827","https://openalex.org/W2092596425","https://openalex.org/W2106109834","https://openalex.org/W2112340715","https://openalex.org/W2128157627","https://openalex.org/W2135248587","https://openalex.org/W2149182910","https://openalex.org/W2163891284","https://openalex.org/W2166279203","https://openalex.org/W2323983957","https://openalex.org/W2339157329","https://openalex.org/W2402650195","https://openalex.org/W2412415478","https://openalex.org/W2474806535","https://openalex.org/W4294309380"],"related_works":["https://openalex.org/W7097483381","https://openalex.org/W2000106454","https://openalex.org/W2412415478","https://openalex.org/W2052071807","https://openalex.org/W7098579326","https://openalex.org/W1993227385","https://openalex.org/W2323983957","https://openalex.org/W2017211926","https://openalex.org/W2571001890","https://openalex.org/W2137602993"],"abstract_inverted_index":{"The":[0,31,108,128],"aim":[1],"of":[2,11,19,26,29,42,49,66,87,93,106,120,131,152,167,212,221,252],"the":[3,9,17,40,67,85,88,94,104,116,121,170,173,185,217],"present":[4],"study":[5],"was":[6,33,115,177],"to":[7,99,169],"investigate":[8],"influence":[10],"classic":[12],"and":[13,72,134,146,182,209],"atypical":[14],"neuroleptics":[15,89,95,187,223],"on":[16,194],"activity":[18,105,154,176,196],"rat":[20],"CYP2B":[21,153,175,195],"measured":[22],"as":[23,44,46,236,238],"a":[24,60,161],"rate":[25],"16":[27],"beta-hydroxylation":[28],"testosterone.":[30],"reaction":[32,123],"studied":[34,122],"in":[35,39,47,84,90,97,199,231,259],"control":[36,100],"liver":[37,101,210],"microsomes":[38,48,102],"presence":[41],"neuroleptics,":[43,172],"well":[45,237],"rats":[50,168],"treated":[51],"intraperitoneally":[52],"for":[53,201],"one":[54],"day":[55],"or":[56,248,256],"two":[57,202],"weeks":[58],"(twice":[59],"day)":[61],"with":[62,224,245],"pharmacological":[63,255],"doses":[64,208],"(mg/kg)":[65],"drugs":[68],"(promazine,":[69],"levomepromazine,":[70,145],"thioridazine":[71,114],"perazine,":[73],"10":[74],"each;":[75],"chlorpromazine":[76],"3;":[77],"haloperidol":[78],"0.3;":[79],"risperidone":[80,147,181,247],"0.1;":[81],"sertindole":[82,135,249],"0.05),":[83],"absence":[86],"vitro.":[91],"ome":[92],"added":[96],"vitro":[98,232],"decreased":[103,174],"CYP2B.":[107],"obtained":[109],"Ki":[110,225],"values":[111,226],"indicated":[112],"that":[113,216],"most":[117],"potent":[118],"inhibitor":[119],"(Ki":[124,138,155],"=":[125,139,156],"26":[126],"microM).":[127],"inhibitory":[129,219],"effects":[130,240],"chlorpromazine,":[132,234],"perazine":[133],"were":[136,148],"moderate":[137],"45-75":[140],"microM),":[141],"while":[142],"promazine,":[143],"haloperidol,":[144,180,246],"rather":[149],"weak":[150],"inhibitors":[151],"125-225":[157],"microM,":[158],"respectively).":[159],"After":[160],"one-day":[162,243],"(i.e.":[163],"24":[164],"h)":[165],"exposure":[166],"investigated":[171,186],"observed":[178],"after":[179],"sertindole.":[183],"All":[184],"did":[188],"not":[189],"produce":[190],"any":[191],"significant":[192],"effect":[193,220],"when":[197],"administered":[198],"vivo":[200],"weeks.":[203],"Considering":[204],"relatively":[205],"high":[206],"pharmacological/therapeutic":[207],"concentrations":[211],"phenothiazines,":[213],"it":[214],"seems":[215],"direct":[218],"those":[222],"below":[227],"100":[228],"microM":[229],"found":[230],"(thioridazine,":[233],"perazine),":[235],"indirect":[239],"produced":[241],"by":[242],"treatment":[244],"may":[250],"be":[251],"some":[253],"physiological,":[254],"toxicological":[257],"importance":[258],"vivo.":[260]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}